人類微生物組製造服務市場規模、佔有率和成長分析：按服務類型、產品類型、製造規模、微生物類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球人類微生物組製造服務市場價值為 11 億美元，預計到 2025 年將成長至 12.7 億美元，到 2033 年將成長至 39.6 億美元，在預測期（2026-2033 年）內複合年成長率為 15.29%。

全球人類微生物組生產服務市場的主要驅動力是微生物組科學與治療和診斷的融合，這推動了對特種菌株開發和GMP（良好生產規範）合規性專業知識的需求。該市場涵蓋了為臨床和商業應用生產生物製藥和新一代益生菌的合約開發和生產組織（CDMO）。微生物群落的調控對於疾病治療和個人化醫療至關重要。隨著定序技術的進步、監管指南的製定以及生物製藥產品相關法規的逐步明確，該行業已從學術研究發展成為可擴展的供應鏈。人工智慧透過最佳化菌株選擇、簡化發酵製程和預測穩定性來增強可擴展性。這使得CDMO能夠提高效率，並透過縮短臨床試驗時間和降低開發風險來擴大生產能力。

全球人類微生物組製造服務市場的成長要素

全球人類微生物組製造服務市場的主要促進因素之一是人們日益認知到人類微生物組在健康和疾病管理中的重要性。隨著研究揭示微生物組與包括肥胖、糖尿病和胃腸道疾病在內的多種健康狀況之間的複雜關聯，對基於微生物組的個人化療法和診斷的需求日益成長。這種日益成長的興趣促使生物技術和製藥公司加大對微生物組研發的投入，從而為能夠支持針對個體健康需求客製化的微生物組相關產品的生產和商業化的製造服務創造了一個強勁的市場。

全球人類微生物組製造服務市場的限制因素

全球人類微生物組製造服務市場的主要限制因素之一是微生物組相關產品嚴格的法規環境。微生物組研究的複雜性要求進行全面的安全性和有效性評估，導致核准流程漫長，阻礙新產品和服務進入市場。此外，不同的區域監管標準也會為旨在實現全球產品部署的公司帶來挑戰。這些障礙會導致營運成本增加和延誤，最終對創新產生負面影響，並限制市場的潛在成長。因此，克服這些監管障礙仍然是行業相關人員面臨的重大挑戰。

全球人類微生物組製造服務市場趨勢

全球人類微生物組生產服務市場正呈現向個人化醫療融合的顯著趨勢。對基於微生物組的個人化干涉措施的激增需求，迫使服務供應商不斷創新並調整其生產能力。各公司日益專注於建立靈活的生產線和擴充性的工作流程，以便根據患者特定的微生物群譜定製配方，並支援客製化生物製藥。加強與臨床醫生和診斷開發人員的合作至關重要，產品設計必須與治療效果和監管要求保持一致。因此，能夠提供涵蓋菌株處理、配方和分銷等全方位端到端解決方案的契約製造製造商正日益受到市場關注。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球人類微生物組製造服務市場規模：依服務類型分類

• 流程開發服務
• 分析和品管(QC) 測試服務
• 臨床製造服務
• 商業製造服務
• 灌裝和精加工服務
• 包裝和標籤服務
• 監理合規服務
• 供應鍊和物流服務

全球人類微生物組製造服務市場規模：依產品類型分類

• 生物醫學產品（LBPs）
• 基於微生物組的藥物
• 糞便微生物移植（FMT）產品
• 益生菌療法
• 合益素產品
• 後生元產品
• 微生物聯合產品
• 其他

全球人類微生物組製造服務市場規模：依製造規模分類

• 臨床前規模生產
• 臨床規模生產
• 商業規模生產

全球人類微生物組製造服務市場規模：依微生物類型分類

• 基於細菌的生產
• 真菌/酵母基製造
• 病毒/噬菌體基礎生產
• 產孢微生物的生產
• 混合微生物群落生產

全球人類微生物組製造服務市場規模：按應用領域分類

• 消化系統疾病
• 感染疾病
• 代謝性疾病
• 腫瘤學
• 神經病變
• 自體免疫/發炎性疾病
• 皮膚病
• 其他

全球人類微生物組製造服務市場規模：依最終用戶分類

• 製藥公司
• 生技公司
• 學術研究機構
• 受託研究機構（CRO）
• 醫院和臨床中心

全球人類微生物組製造服務市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Arranta Bio
• Bacthera
• Biose Industrie
• Cerbios-Pharma
• List Labs
• Lonza
• Evonik Industries
• Eurofins Scientific
• Catalent
• Recipharm
• Kaneka Eurogentec
• Aenova Group
• Vibalogics
• Quay Pharmaceuticals
• NIZO
• Genome & Company
• Probiotical Research
• KBI Biopharma
• Cambrex
• Thermo Fisher Scientific

結論與建議

Global Human Microbiome Manufacturing Services Market size was valued at USD 1.1 Billion in 2024 and is poised to grow from USD 1.27 Billion in 2025 to USD 3.96 Billion by 2033, growing at a CAGR of 15.29% during the forecast period (2026-2033).

The global human microbiome manufacturing services market is primarily fueled by the integration of microbiome science into therapeutics and diagnostics, driving demand for specialized strain development and GMP expertise. This market encompasses contract development and manufacturing organizations that create live biotherapeutics and next-gen probiotics for clinical and commercial applications. The manipulation of microbial communities is pivotal for disease treatment and personalized care. With advancements in sequencing and regulatory guidance, the industry has evolved from academic endeavors to scalable supply chains, propelled by increased regulatory clarity on live products. AI enhances scalability by optimizing strain selection, streamlining fermentation processes, and predicting stability, thereby reducing time to clinic and development risks, enabling CDMOs to improve efficiency and drive growth in manufacturing capabilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Microbiome Manufacturing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Microbiome Manufacturing Services Market Segments Analysis

Global human microbiome manufacturing services market is segmented by service type, product type, manufacturing scale, microorganism type, application, end user and region. Based on service type, the market is segmented into Process Development Services, Analytical & QC Testing Services, Clinical Manufacturing Services, Commercial Manufacturing Services, Fill-Finish Services, Packaging & Labeling Services, Regulatory Support Services and Supply Chain & Logistics Services. Based on product type, the market is segmented into Live Biotherapeutic Products (LBPs), Microbiome Drugs, Fecal Microbiota Transplantation (FMT) Products, Probiotic Therapeutics, Synbiotic Products, Postbiotic Products, Microbial Consortia Products and Others. Based on manufacturing scale, the market is segmented into Preclinical Scale Manufacturing, Clinical Scale Manufacturing and Commercial Scale Manufacturing. Based on microorganism type, the market is segmented into Bacteria-Based Manufacturing, Fungi/Yeast-Based Manufacturing, Viral/Phage-Based Manufacturing, Spore-Forming Microbe Manufacturing and Mixed Microbial Consortia Manufacturing. Based on application, the market is segmented into Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders, Oncology, Neurological Disorders, Autoimmune & Inflammatory Disorders, Dermatological Disorders and Others. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs) and Hospitals & Clinical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Microbiome Manufacturing Services Market

One of the key market drivers for the Global Human Microbiome Manufacturing Services Market is the rising awareness of the significance of the human microbiome in health and disease management. As research uncovers the intricate relationship between microbiota and various health conditions, including obesity, diabetes, and gastrointestinal disorders, there is an increasing demand for customized microbiome-based therapeutics and diagnostics. This growing interest encourages biotech and pharmaceutical companies to invest in microbiome research and development, creating a robust market for manufacturing services that can support the production and commercialization of microbiome-related products tailored to individualized health needs.

Restraints in the Global Human Microbiome Manufacturing Services Market

One significant market restraint for the Global Human Microbiome Manufacturing Services Market is the stringent regulatory environment surrounding microbiome-related products. The complex nature of microbiome research necessitates comprehensive safety and efficacy evaluations, leading to prolonged approval processes that can hinder the entry of new products and services. Additionally, varying regulatory standards across regions may create challenges for companies looking to globalize their offerings. These obstacles can lead to increased operational costs and delays, ultimately impacting innovation and limiting the market's potential growth. As such, navigating through these regulatory barriers remains a critical concern for industry stakeholders.

Market Trends of the Global Human Microbiome Manufacturing Services Market

The Global Human Microbiome Manufacturing Services market is witnessing a significant trend towards personalized therapeutics integration. This surge in demand for individualized microbiome-based interventions is prompting service providers to innovate and adapt their manufacturing capabilities. Companies are increasingly focusing on establishing flexible production lines and scalable workflows that cater to bespoke live biotherapeutics, tailoring formulations to match patient-specific microbiota profiles. Enhanced collaboration with clinicians and diagnostics developers is becoming paramount, aligning product design with therapeutic outcomes and regulatory requirements. As a result, contract manufacturers that offer comprehensive end-to-end solutions, encompassing strain handling, formulation, and distribution, are gaining heightened prominence in the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Human Microbiome Manufacturing Services Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Process Development Services
• Analytical & QC Testing Services
• Clinical Manufacturing Services
• Commercial Manufacturing Services
• Fill-Finish Services
• Packaging & Labeling Services
• Regulatory Support Services
• Supply Chain & Logistics Services

Global Human Microbiome Manufacturing Services Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Live Biotherapeutic Products (LBPs)
• Microbiome Drugs
• Fecal Microbiota Transplantation (FMT) Products
• Probiotic Therapeutics
• Synbiotic Products
• Postbiotic Products
• Microbial Consortia Products
• Others

Global Human Microbiome Manufacturing Services Market Size by Manufacturing Scale & CAGR (2026-2033)

• Market Overview
• Preclinical Scale Manufacturing
• Clinical Scale Manufacturing
• Commercial Scale Manufacturing

Global Human Microbiome Manufacturing Services Market Size by Microorganism Type & CAGR (2026-2033)

• Market Overview
• Bacteria-Based Manufacturing
• Fungi/Yeast-Based Manufacturing
• Viral/Phage-Based Manufacturing
• Spore-Forming Microbe Manufacturing
• Mixed Microbial Consortia Manufacturing

Global Human Microbiome Manufacturing Services Market Size by Application & CAGR (2026-2033)

• Market Overview
• Gastrointestinal Disorders
• Infectious Diseases
• Metabolic Disorders
• Oncology
• Neurological Disorders
• Autoimmune & Inflammatory Disorders
• Dermatological Disorders
• Others

Global Human Microbiome Manufacturing Services Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Hospitals & Clinical Centers

Global Human Microbiome Manufacturing Services Market Size & CAGR (2026-2033)

• North America (Service Type, Product Type, Manufacturing Scale, Microorganism Type, Application, End User)
  • US
  • Canada
• Europe (Service Type, Product Type, Manufacturing Scale, Microorganism Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Product Type, Manufacturing Scale, Microorganism Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Product Type, Manufacturing Scale, Microorganism Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Product Type, Manufacturing Scale, Microorganism Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Arranta Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bacthera
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biose Industrie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerbios-Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• List Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Eurogentec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aenova Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vibalogics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quay Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIZO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genome & Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Probiotical Research
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KBI Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations